Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Barrett

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Talanta|December 11, 2020
Rate normalization for sweat metabolomics biomarker discoverySean W Harshman, Kraig E Strayer, Christina N Davidson, et al.
Nature|April 24, 2024
Probing entanglement in a 2D hard-core Bose-Hubbard latticeAmir H Karamlou, Ilan T Rosen, Sarah E Muschinske, et al.
Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
European Journal of Human Genetics : EJHG|November 19, 2015
Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionalsMelissa Hill, Jo-Ann Johnson, Sylvie Langlois, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Talanta|December 11, 2020
Rate normalization for sweat metabolomics biomarker discoverySean W Harshman, Kraig E Strayer, Christina N Davidson, et al.
Nature|April 24, 2024
Probing entanglement in a 2D hard-core Bose-Hubbard latticeAmir H Karamlou, Ilan T Rosen, Sarah E Muschinske, et al.
Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
European Journal of Human Genetics : EJHG|November 19, 2015
Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionalsMelissa Hill, Jo-Ann Johnson, Sylvie Langlois, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Pageof 22